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Solid lipid nanoparticles (SLN) were recently proposed as carriers for various pharmaceutical and cosmetic 
actives. These lipid nanoparticles can act as moisturizers and physical sunscreens on their own. Therefore, 
the full potential of these carriers has yet to be determined. The present study was aimed to determine 
and compare moisturizing and UV-protecting effects of different solid lipid nanoparticles (SLN) prepared 
by different solid lipids including Glyceryl monostearate (GMS), Precirol® (P) and cetyl palmitate (CP) 
as carrier systems of moisturizers and sunscreens. The influence of the size and matrix crystallinity of 
the solid lipids on the occlusive factor, skin hydration and UV-protection were evaluated by in vitro and 
in vivo methods. The SLN were prepared by high-shear homogenization and ultrasound methods. Size, 
zeta potential and morphological characteristics of the samples were assessed by transmission electron 
microscopy (TEM) and thermotropic properties with differential scanning calorimetry (DSC) technique. 
Results of the assessments showed that SLN-CP significantly increases skin hydration and UV-protection, 
compared to SLN-GMS and SLN-P. It was demonstrated that the size of SLN, crystallinity index of solid 
lipid in SLN and probably other mechanisms besides the occlusive factor can influence skin hydration 
and UV-protection indices. Furthermore, findings of the assessments demonstrated significant difference 
between in vitro and in vivo assessments regarding occlusive factor and moisturizing effects. Findings of 
the present study indicate that the SLN-CP could be a promising carrier for sunscreens and moisturizers.
Uniterms: Solid lipid nanoparticles/moisturizing effects. Solid lipid nanoparticles/UV protecting.
Nanopartículas lipídicas sólidas (NLS) foram, recentemente, propostas como carreadores de vários ativos 
cosméticos e farmacêuticos. Essas nanopartículas lipídicas podem atuar como hidratantes e protetores 
solares físicos por si só. Assim sendo, determinou-se o potencial desses carreadores. Os objetivos do 
presente estudo foram determinar e comparar os efeitos hidratantes e protetores contra UV das diferentes 
partículas lipídicas sólidas (NLS) preparadas com diferentes lipídios sólidos, incluindo o monoestearato 
de gligerila (MSG), Precirol® (P) e palmitato de cetila (PC) como sistemas carreadores de hidratantes 
e de protetores solares. A influência do tamanho e da cristalinidade da matriz dos lipídios sólidos no 
fator oclusivo, na hidratação da pele e na proteção ao UV foi avaliada por métodos in vitro e in vivo. As 
NLS foram preparadas por homogeneização por alto corte e métodos de ultrassom. Tamanho, potencial 
zeta e características morfológicas das amostras foram determinados por microscopia de transmissão 
eletrônica (MTE) e as propriedades termotrópicas, com diferentes técnicas de calorimetria diferencial 
de varredura (CDV). Os resultados mostraram que NLS-PC aumenta significativamente a hidratação 
da pele e a proteção ao UV, comparativamente à NLS-MSG e à NLS-P. Demonstrou-se que o tamanho 
da NLS, índice de cristalinidade do lipídio sólido na NLS e, provavelmente, outros mecanismos além 
do fator oclusivo podem influenciar a hidratação da pele e os índices de proteção ao UV. Além disso, os 
resultados mostraram diferença significativa entre as avaliações in vitro e in vivo com relação ao fator 
oclusivo e aos efeitos hidratantes. Os resultados do presente estudo indicam que NLS-PC poderia ser 
um carreador promissor para protetores solares e hidratantes. 
Unitermos: Nanopartículas lipídicas sólidas/efeitos hidratantes. Nanopartículas lipídicas sólidas/
proteção ao UV.
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INTRODUCTION
Sunlight exposure can be both beneficial and harm-
ful for the human body. It has been known for decades that 
sunscreens are capable of protecting human body of solar 
radiation-induced harmful effects (Kullavanijaya et al., 
2005; Potard et al., 2000). Since sunscreens should act on 
the surface of the skin, they should penetrate as little as 
possible into the viable epidermis, the dermis and into the 
systemic circulation (Potard et al., 2000).
Several factors are involved in the transdermal deliv-
ery of drugs and cosmetic actives, from topically-applied 
formulations. The penetration and the effectiveness of 
active compounds through the human skin depends on 
physicochemical properties of the drug, size of the mol-
ecule, drug-delivery system, lipophilicity of components, 
vehicle and skin hydration which can be influenced by 
occlusive and other compounds (Verma et al., 2003; Zhai 
et al., 2002).
Solid lipid nanoparticles (SLN) have been intro-
duced as a novel drug-delivery systems for pharmaceu-
tical drugs and cosmetic active ingredients due to their 
advantages over conventional formulations (Muller et al., 
2000; Wissing et al., 2003a). They are promising carriers 
as protecting labile active compounds from degradation 
(Jenning et al., 2001; Muller et al., 2000), releasing active 
ingredients in a controlled way (Zur Muhlen et al., 1998; 
Maia et al., 2000), increasing skin water content, (Wiss-
ing et al., 2001; Wissing et al., 2002b) and UV-blocking 
potential as physical sunscreens (Wissing et al., 2001b; 
Wissing et al., 2002a).
The occlusive property of the SLN is due to its film 
formation after application through the skin. The extent of 
the occlusive properties depends on various factors, e.g. 
particles size, lipid and lipid concentration. The UV pro-
tection is based on the UV reflecting and scattering abil-
ity like other physical sunscreens (Wissing et al., 2001b; 
Wissing et al., 2002a; Wissing et al., 2002b).
The occlusive and UV-blocking properties of SLN 
can introduce them as a promising vehicle for the moistur-
izer and sunscreen products.
It was observed by other researches that the oc-
clusion factor of lipid microparticles was only 10%, 
compared to 50% when using lipid nanoparticles of ap-
proximately 200 nm (Souto et al., 2008). Meanwhile it 
was found that among Dynasan 112, Compritol 888 ATO 
and Softisan 154 as solid lipids in SLN; the highest occlu-
sion will be achieved from low melting lipids with highly 
crystalline particles (Wissing et al., 2003b). These studies 
do not fully mimic the natural moisture loss conditions and 
there was no comparison between in vitro and in vivo skin 
hydration. SLN have been also introduced as a novel car-
rier for sunscreen ingredients. UV protecting of different 
lipids in SLN formulations were not investigated by SPF 
determination in vitro method.
In this study, we investigated and compared the in-
fluence of size and crystallinity of different lipid composi-
tion in SLN formulations on the occlusion factor using in 
vitro method and the skin hydration using corneometer in 
vivo method. UV protection properties of different lipids 
in SLN formulations were also investigated by Transpore 
tape 3M in vitro method.
MATERIAL AND METHODS
Material
Glyceryl palmitostearate (Precirol® ATO 5) and 
glyceryl monostearate (GMS) were gifted by Gattefossé 
(Pvt. Ltd., France). Cetyl palmitate (CP) and Tween 80 
were purchased from Sigma-Aldrich (Deisenhofen Ger-
many). Poloxamer188 was obtained from Uniqema (Ev-
erberg, Belgium). All of the original samples were used 
as their arrival. Water was used a double-distilled water.
Preparation of SLN
The SLN were prepared by high-shear homogeniza-
tion and ultrasound method. Precirol® ATO 5, GMS and 
CP (1 g) were melted by heating at 5 ºC above the melting 
point of the lipids. The aqueous phase was prepared by 
dissolving tween 80 (0.5 g) for GMS and CP, or poloxamer 
188 (0.5 g) for Precirol® ATO 5 in double-distilled water 
(10 ml of the solution was produced) and that was heated 
up to the melting point temperature of the lipid phase. 
Hot aqueous phase was added to the molten lipid phase 
and homogenized by Diax 900 homogenizer (Heidolph, 
Germany) for 2 min at 11,000 rpm. The temperature was 
kept at 5 ºC above the melting point of the lipid. Coarse 
hot oil in water emulsion obtained was ultrasonicated by 
Prob Sonicator (Bransonic, USA). The prob sonication 
was performed at 6 cycles with 30 seconds of sonication 
separated by intervals of 15 seconds. The obtained nano-
emulsions were cooled to room temperature(Kumar et al., 
2007; Venkateswarlu et al., 2004).
Characterization of SLN
Particle size and zeta potentials
Dynamic light scattering (ZetaSizer Nano-ZS; 
Malvern Instruments Ltd., United Kingdom) method was 
used to assess the mean particle size, polydispersity index 
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and zeta potential of the SLN formulations. All measure-
ments were performed in triplicate at a temperature of 25 
ºC ± 2 ºC and an angle of 90 ºC to the incident beam. No 
multi-scattering phenomenon was observed during the 
assessments.
Transmission electron microscopy (TEM)
TEM assessment (TEM; CEM 902A; Zeiss, 
Oberkochen, Germany) was performed to characterize the 
morphology of SLN formulations. The SLN were diluted 
50 times with water and then placed on a carbon-coated 
copper grid for 30 seconds and the excess water was wiped 
off by a filter paper. Then 20 µL of uranyl acetate 2% in 
water covered on SLN and after 30 seconds were wiped 
off by filter paper. The grid was dried at room temperature 
and then assessed by TEM (Liu et al., 2007).
Differential Scanning Calorimetry (DSC)
Melting and recrystallization behavior of crystalline 
materials were assessed using Mettler DSC 821e (Mettler 
Toledo, Gießen, Germany. DSC scans of the bulk lipids 
and SLN formulations were carried out. An empty alumi-
num pan served as reference. Samples were scanned from 
25 ºC to 100 ºC (5 ºC/min) under nitrogen atmosphere (20 
mL/min); then, the melting point of SLN formulations was 
compared to the bulk lipid. Before the DSC measurements, 
the bulk lipids were heated up to 75 ◦C and cooled to the 
room temperature to imitate the production conditions. 
Analysis was carried out under nitrogen purge (Jenning 
et al., 2001; Wissing et al., 2002a).
Occlusive Properties Assessment
For the occlusion test, 100 mL beakers were filled 
with 50 mL water and covered with filter paper (cellulose 
acetate filter, cutoff size: 4-7 µm) and sealed. Samples 
were spread on the filter surface (13.3 mg/cm2) and stored 
at 32 ºC and 50%-55% Relative Hydration (PH) for 48 h. 
Beakers covered with filter paper with no sample, were 
considered as reference. The occlusion factor (F) was cal-
culated according to the following Equation (Eq.1) After 
24 h and 48 h, where A is the water loss without sample 
(reference), and B is the water loss with sample. Every 
experiment was carried out in triplicate (Wissing et al., 
2002b; Souto et al., 2004).
 F=100× ((A−B)/A)  Eq. 1
Skin hydration measurement using Corneometer
The moisture content of the skin was measured by 
a corneometer (Courage, Khazaka, Cologne, Germany) 
following application of different SLN formulations. The 
test was carried out on 6 volunteers with normal skin at 
room temperature (ages were between 20 and 35 years). 
Before the measurements, subjects were given time to 
adapt to room conditions without covering the measuring 
sites. On the day of examination, the skin was not washed 
and nothing was applied to the skin surface. Subjects were 
instructed not to apply any preparation to the site to be 
examined one week before investigation. The corneometer 
CM 820 was used to determine the humidity level of the 
stratum corneum by measuring electrical capacitance. All 
the measured values were expressed as the median of three 
recordings. The measurements were carried out on exactly 
the same sites. The measuring place was in the middle of 
the forearm. In the first instant, the moisture content of the 
skin without any application of the product was measured, 
and then the measurement was carried out after 30 min, 
2, 3, 6 and 10 hours after application of the sunscreens 
(Sator et al., 2003).
SPF determination of the formulations using Transpore 
tape in vitro method
The principle of this method is based on the mea-
surement of the spectral transmittance of UVR through a 
sample of a surgical tape which is called Transpore tape 
with and without the sunscreen applied. This substrate was 
introduced first by Diffey (Diffey, 2002). SLN formula-
tions and sunscreen standard were applied on the surface 
of the TransporeTM tape at 2 mg/cm2. After 15 minutes 
transmission was measured from 290 nm to 400 nm at 
intervals of 5 nm at five distinct points. The predicted SPF 
value was calculated according to the following equation 
(Eq. 2).
   Eq. 2
In this equation: E(λ): CIE Relative Erythemal 
Spectral Effectiveness, S(λ): Solar Spectral Irradiance 
(Wm-2nm-1), T(λ): Spectral Transmittance of the sample 
(as measured on the UV-1000S). Results were reported as 
mean SPFs and relative standard deviations as percentage 
of the mean SPF.
Data analysis
All the experiments of each preparation were re-
peated three times, and data were expressed as the mean 
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value ± S.D. The statistical data were analyzed using 
nonparametric with a Tukey-Kramer test. Results with P 
< 0.05 were considered statistically significant.
RESULTS AND DISCUSSION
Three types of SLN were prepared by high-shear 
homogenization and ultrasound method. Homogeniza-
tion, followed by ultrasonication, is a simple, reliable and 
reproducible method for SLN preparation (Venkateswarlu 
et al., 2004). The process parameters, involved in the 
preparation of SLN were optimized, including lipid and 
surfactant (type and concentration), lipid/surfactant ratio, 
homogenization and sonication time to reduce the size of 
nanoparticles with narrow size distribution. Physically 
stable SLN with a narrow size distribution were produced. 
To obtain stable and smaller SLN, sonication cycles, were 
varied from 6 to 20 and their effect on particle size was 
measured. It was obtained that in 12 and 20 cycles, the PI 
of the SLN distribution was increased with no significant 
difference in the mean size of the particles. Therefore, 6 
cycles were used for the preparations.
The mean diameter (z-average), PI and zeta potential 
of the bulk population of the particles, were measured by 
particle size analyzer (PSA), which are shown in Table I. 
Among the lipids used, GMS and Precirol produced sig-
nificantly smaller size of SLN, compared CP. In addition, 
no significant difference of the size between SLN-GMS 
and SLN-P were obtained. The difference between the 
mean particle size and particle size distribution is because 
of the difference of the type of lipid and emulsifier in dif-
ferent SLN formulations. GMS is a surface active partial 
glyceride which facilitated emulsification and formed 
more rigid surfactant films and then improved the long-
term stability of SLN (Hou et al., 2003).
Zeta potential can make a prediction about the stabil-
ity of colloid dispersions. A high zeta potential (>30 mV) 
can provide an electric repulsion to avoid the aggregation 
of the particles (Levy et al., 1994). The zeta potentials 
of SLN-GMS and SLN-P were above -35mV which was 
physically more stable than SLN-CP.
The TEM imaging of SLN-GMS, SLN-CP and SLN-
P SLN are shown in Figure 1. It was observed all of the 
SLN formulations exhibited nanometric size, spherical 
shape and had a narrow size distribution. There was no 
difference between the particle size of from TEM images 
and PSA.
To determine the extent of crystallinity, the samples 
were investigated by differential scanning calorimetry 
(DSC). Samples were scanned from 25 ºC to 100 ºC 
TABLE I - The particle size, polydispersity Index (PI) and Zeta potential of different SLN formulations measured by PSA. Data 
expressed as Mean ± SD (n = 3) (according to the zeta average), * Statistical significance with SLN-GMS and SLN-CP (p < 0.05), 
not significant with SLN-GMS and SLN-P (p > 0.05)
Formulation Particle size (nm) Polydispersity Index (PI) Zeta Potential (mV)
SLN-GMS 165.3±5.56 0.24±0.06 -45.21±2.1
SLN-CP 245.13±10.32 0.28±0.01 -27.33±6.02
SLN-P 162.6±5.3 0.32±0.01 -36.46±3.44
FIGURE 1 - The TEM images of a) SLN-GMS and b) SLN-CP c) SLN-P prepared by high- shear homogenization and ultrasound 
method.
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(5 ºC/min) and the melting point of SLN formulations 
was compared to the bulk lipid. The DSC scans of the 
formulations and the bulk lipids are shown in Figure 2. 
The melting peak of pure GMS, Precirol and CP proved 
the solid character of the lipid matrix at room temperature 
as they are higher than room temperature. The thermo-
gram in Figure 2 (A) and (B) shows that the SLN-GMS 
and SLN-Precirol depressed the transition temperature 
of the lipids to a lower temperature and also changed the 
structure of the peak. The two thermal maxima in the DSC 
melting of SLN-P curve indicate melting of two different 
crystalline forms.
The depression of the melting temperature in SLN is 
due to the lower size and the structure of the SLN. These 
Figures also showed that the lipid does not recrystallize 
completely at room temperature however, SLN-CP (Figure 
2 (C)) forms highly crystalline lipid nanoparticles and 
recrystallize completely.
The extent of crystallinity was investigated by DSC. 
The peak location of SLN-GMS is slightly shifted towards 
lower temperatures compared to that of the bulk lipid. The 
recrystallization of the SLN occurred at lower tempera-
tures than the bulk material. The decline of the scan can be 
explained by the small particle sizes of the SLN formula-
tions, their high specific surface area and the presence of 
a surfactant (Saupe et al., 2005). It was demonstrated that 
when the drug is added into SLN, the lipid crystals in an 
orderly situation were further disrupted which can reduce 
the crystallization property of nanoparticles. Therefore, 
the crystallinity of the lipid gradually declines from GMS 
to SLN-GMS as was shown in Li et al research (Li et al., 
2010).
The dependency of the occlusion factor (F) upon the 
size and crystanillity of the SLN formulations is shown 
in Figure 3.
No significant difference of the occlusive factor 
between SLN formulations was observed after 24 and 
48h. Increasing the particle size in SLN-CP towards SLN-
GMS and SLN-P showed a decrease in occlusive factor 
although the high crystanillity of SLN-CP may enhance 
the occlusive factor, therefore, the crytanillity effect can 
modify the size effect on occlusive factor.
In the current study, it was observed that the oc-
clusive factor depends on the size of the particles and 
crystallinity of the lipids in the SLN formulations. Find-
ings of the study conducted by Wissing et al. 2003b), 
also confirms that, the dependence of occlusion factor 
on the particle size of SLN-CP. High occlusion fac-
tors of 50-60 obtained when the particle size was lower 
than 400 nm. Lipid micro-particles were only slightly 
occlusive .
FIGURE 2 - Differential scanning calorimetry thermograms of 
(A) Red: GMS bulk, Black: SLN-GMS, (B) Red: Precirol, Black: 
SLN-P and (C) Red: CP, Black: SLN-CP, SLN formulations 
prepared by high- shear homogenization and ultrasound method.
Skin hydration measurement using Corneometer
In vitro studies do not fully mimic the natural condi-
tions. Therefore, the in vivo studies have to be carried out 
(Souto et al., 2008). It was demonstrated that the occlu-
sion factor is dependent upon the sample volume, particle 
size, crystallinity, lipid concentration and type of colloidal 
systems (Wissing et al., 2002b; Souto et al., 2004).
The effect of SLN on skin hydration has been further 
investigated in a blind, placebo-controlled in vivo study 
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and compared to the in vitro results. The skin hydration 
was measured with a corneometer CM 825 (Courage, 
Khazaka, Germany).
Figure 4 shows the normalized (RCU, Relative 
Corneometer Units) hydration values for the readings 
of the reference site measured with corneometer for the 
SLN formulations at 1, 3 and 5 hours post application vs. 
baseline without application (control). SLN-CP and SLN-
GMS significantly increased the moisture content of the 
skin compared to control point times (p<0.01). Figure 4 
shows that SLN-CP increases skin hydration higher than 
SLN-P and SLN-GMS. The trend of the curves in all the 
treatment groups was nearly the same. At 1 hour applica-
tion, the highest water content was observed for SLN-CP; 
after 3 hours the moisture contents were decreased in all 
of the formulations.
In this study, the corneometer was used and calibrat-
ed to the base line value for each subject before applying 
the formulations on the skin. It can be remarked that the 
extent of hydration of SLN formulations correlates not 
only with particle size and lipid concentration but also with 
the degree of crystallinity of the lipid matrix and probably 
other mechanisms (Wissing et al., 2002b). When applying 
lipid particles onto the skin, a film layer will be formed, 
having a surface area which is dependent on the particle 
size. In small sizes, the dimensions of the air channels will 
be much smaller; thus, the hydrodynamic evaporation of 
water will decrease (Wissing et al., 2003b; Souto et al., 
2008). An in vivo study showed that addition of 4% SLN 
to a conventional o/w cream lead to higher increase of 
skin hydration compared to the conventional cream after 
4 weeks compared to the conventional cream (Wissing et 
al., 2003b). During the first 30 minutes after application, 
the level of water content is usually higher than normal. 
Measurement of water content of skin at this time may 
result in erroneous data (Alanen et al., 2004; Golmoham-
madzadeh et al., 2007). Therefore, the first measured time 
was 30 minute after application. In the current in vivo study 
it was observed the crystallinity of the lipids has more ef-
fective than the size in the sizes below 300 nm. SLN-CP 
with highly crystalline lipid nanoparticles has shown more 
hydration on skin than SLN-GMS and SLN-P with does 
not recrystallize completely.
It was shown that SLN-CP with higher particle sizes 
and the same occlusive factor demonstrated higher skin 
hydration. The results of the in vivo study show that the 
other mechanisms besides the occlusive factor can influ-
ence on skin hydration; like Lubrication, smoothness, 
hygroscopic and emolliency in human.
The ability of SLN formulations to UV radia-
tion blocking was assessed in vitro with Transpore tape 
method. Figure 5 shows the absorption profiles of SLN-
CP, SLN-P and SLN-GMS. It can be clearly seen that the 
absorption profiles varied from one type of solid lipid in 
SLN formulations to another. The SPF of SLN-GMS, 
SLN-P and SLN-CP were obtained 1.46 ± 0.03, 2.38 ± 
0.09 and 3.31 ± 0.35 respectively.
Regarding the Transpore tape in vitro method re-
FIGURE 3 - The Occlusion factor of SLN-GMS, SLN-CP and 
SLN-P after 24 h and 48 h as a function of the particle size of 
the SLN formulations.
FIGURE 4 - Normalized relative hydration values after 
application of SLN-P, SLN-CP and SLN-GMS vs. control 
without application of the product (n = 6).
FIGURE 5 - Absorption spectra (280-400 nm) of SLN-CP, 
SLN-P and SLN-GMS measured by UV spectrophotometer.
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sults, SLN-CP formulations show the highest UV protec-
tion abilities because of owing to the high crystallinity of 
the solid lipid than the other solid lipids. As previously 
published, increased crystallinity improves UV-blocking 
effect (Xia et al., 2007). The solid nanoparticles in SLN 
formulations are able to scatter and reflect UV radiation, 
leading to a decrease of the outgoing UV light. Thus, incor-
poration a UV-blocker into a carrier system having a UV-
blocking effect on its own and thus increasing the overall 
UV-blocking effect is expected (Wissing et al., 2003a; 
Wissing et al., 2001a). Cengiz et al showed that t it is pos-
sible to obtain a high UV- protection effect even though 
the solid lipid content or the amount of the sunscreen agent 
is decreased. Incorporation of TiO2 as a sunscreen agent 
into SLN formulations gives opportunity to produce stable 
and safe formulations with reduced amount of the TiO2 but 
high UV- protection ability (Cengiz et al., 2006).
SLN act as physical sunscreens, therefore, the con-
centration of potentially hazardous molecular sunscreen 
can be decreased while maintaining the sun protection 
factor. SLN are able to provide a sustained release carrier 
system, therefore the sunscreen remains longer on the 
surface of the skin where it is intended to act (Wissing et 
al., 2003a; Wissing et al., 2002). Thus concentration of 
UV blockers can be decreased. It was shown that physical 
and chemical sunscreens can be incorporated to the SLN 
formulations (Wissing, et al., 2001a). SLN-CP showed 
better UV protection and introduced as a good carrier for 
incorporating sunscreens and indicated better moisturizing 
effect by in vivo method.
CONCLUSION
The results showed that the SLN-CP has more abil-
ity to hydrate skin and protect skin against UV irradiation 
compared to SLN-GMS and SLN-P. The results also dem-
onstrated that the crystallinity and occlusive factor of solid 
lipid besides some other factors can influence on skin hydra-
tion. Also the crystallinity of solid lipid in SLN formulations 
is more effective on UV- protection effects than the size of 
SLN. It was also indicated that the occlusive factor obtained 
by in vitro study does not simulate the skin hydration by in 
vivo study. These results showed that the SLN-CP could be 
a promising carrier for sunscreens and moisturizers.
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